1038 related articles for article (PubMed ID: 29169144)
1. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Krishnamurthy N; Kurzrock R
Cancer Treat Rev; 2018 Jan; 62():50-60. PubMed ID: 29169144
[TBL] [Abstract][Full Text] [Related]
2. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.
Ashihara E; Takada T; Maekawa T
Cancer Sci; 2015 Jun; 106(6):665-671. PubMed ID: 25788321
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
[TBL] [Abstract][Full Text] [Related]
4. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
[TBL] [Abstract][Full Text] [Related]
5. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
7. Huaier aqueous extract inhibits stem-like characteristics of MCF7 breast cancer cells via inactivation of hedgehog pathway.
Wang X; Zhang N; Huo Q; Sun M; Dong L; Zhang Y; Xu G; Yang Q
Tumour Biol; 2014 Nov; 35(11):10805-13. PubMed ID: 25077927
[TBL] [Abstract][Full Text] [Related]
8. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
9. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
11. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
[No Abstract] [Full Text] [Related]
12. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
14. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
Distler A; Lang V; Del Vecchio T; Huang J; Zhang Y; Beyer C; Lin NY; Palumbo-Zerr K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1264-8. PubMed ID: 24445254
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
Takebe N; Harris PJ; Warren RQ; Ivy SP
Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
[TBL] [Abstract][Full Text] [Related]
16. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
[TBL] [Abstract][Full Text] [Related]
17. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.
Mukherjee N; Panda CK
Clin Breast Cancer; 2020 Oct; 20(5):361-370. PubMed ID: 32416986
[TBL] [Abstract][Full Text] [Related]
19. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.
Rodilla V; Villanueva A; Obrador-Hevia A; Robert-Moreno A; Fernández-Majada V; Grilli A; López-Bigas N; Bellora N; Albà MM; Torres F; Duñach M; Sanjuan X; Gonzalez S; Gridley T; Capella G; Bigas A; Espinosa L
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6315-20. PubMed ID: 19325125
[TBL] [Abstract][Full Text] [Related]
20. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.
Ungerbäck J; Elander N; Grünberg J; Sigvardsson M; Söderkvist P
PLoS One; 2011 Mar; 6(3):e17957. PubMed ID: 21437251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
